You are here

Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale.

TitleMolecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale.
Publication TypeJournal Article
Year of Publication1999
AuthorsPalmer, GH, Rurangirwa, FR, Kocan, KM, Brown, WC
JournalParasitol Today
Volume15
Issue7
Pagination281-6
Date Published1999 Jul
ISSN0169-4758
KeywordsAnaplasma, Anaplasmosis, Animals, Antibody Formation, Antigenic Variation, Antigens, Bacterial, Antigens, Surface, Bacteremia, Bacterial Proteins, Cattle, Cattle Diseases, Epitopes, Immunity, Cellular, Ticks
Abstract

Anaplasma marginale is a tick-transmitted ehrlichial pathogen causing severe morbidity and mortality in livestock on six continents. Development of safe effective vaccines would be greatly facilitated by identification of the protective immune mechanisms and by understanding how the pathogen evades immune effectors to establish persistent infection. In this article, Guy Palmer and colleagues review recent progress in identifying how defined epitopes induce protective immunity and the role of antigenic variation in these epitopes as a mechanism of persistence.

Alternate JournalParasitol. Today (Regul. Ed.)
PubMed ID10377531